ACAD
ACADIA Pharmaceuticals Inc
Price:  
21.57 
USD
Volume:  
2,079,323
United States | Biotechnology

Acadia Gross Margin

As of 2025-07-10, the Gross Margin of ACADIA Pharmaceuticals Inc (ACAD) is 91.5%.

Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.

Acadia Gross Margin - Historical Value
DateValue
2024-12-31 91.5%
2023-12-31 94.2%
2022-12-31 98%
2021-12-31 96.3%
2020-12-31 95.3%
2019-12-31 94.2%
2018-12-31 91.8%
2017-12-31 89.5%
2016-12-31 74.6%
2015-12-31 -2400%
Acadia Gross Margin - Peers Comparison